CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8,734 enrolled
Drug / intervention
Behaviorally enhanced reminder letterbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05609396
NCT05609396N/ACompleted

Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial

Dublin City University·interventional·Posted Nov 8, 2022·Updated Nov 14, 2022

In Brief

A clinical study evaluating Behaviorally enhanced reminder letter for Colorectal Cancer. Completed, enrolled 8,734 participants across 1 site.

Detailed Summary

High uptake is vital to population-based screening. BowelScreen (Irelands national organised population-based colorectal cancer screening programme) has not achieved recommended screening uptake targets. In Ireland sending the test kit in the screening invitation reminder may be an important strategy in targeting non-responders and would address a key difference between Ireland and other international screening programmes with higher uptake. In addition, few studies have focused on behavioural barriers to screening participation. Founded upon the MRC Guidelines for the Development of Complex Interventions, our systematic, theoretically-informed investigation of FIT screening participation has begun to identify behavioural antecedents to screening participation in Ireland. This study will implement a multilevel evidence-based, theoretically-informed intervention which includes the automatic inclusion of the test kit in the screening reminder, alone and in combination with an intervention to influence individuals' screening participation. This multilevel intervention will provide recommendations for the screening invitation delivery, potentially bringing the programme closer to recommended uptake targets (50%) and in the long-term influence reductions in bowel cancer incidence and mortality in Ireland.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIreland

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 8, 2022
Enrollment StartMay 3, 2022
Primary CompletionOct 24, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.6 years ago

Interventions

Behaviorally enhanced reminder letterbehavioral

Behavioral interventions to increase FIT-based colorectal cancer screening uptake